Stock VTYX VENTYX BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Ventyx Biosciences, Inc.

Equities

VTYX

US92332V1070

Market Closed - Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
2.22 USD +3.74% Intraday chart for Ventyx Biosciences, Inc. -7.11% -10.12%
Jul. 01 Ventyx Biosciences, Inc.(NasdaqGS:VTYX) added to Russell Microcap Value Index CI
Jul. 01 Ventyx Biosciences, Inc.(NasdaqGS:VTYX) added to Russell 3000E Value Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) added to Russell Microcap Value Index
CI
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) added to Russell 3000E Value Index
CI
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) dropped from Russell 3000E Growth Index
CI
Transcript : Ventyx Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:40 AM
Oppenheimer Adjusts Ventyx Biosciences Price Target to $10 From $12, Maintains Outperform Rating
MT
Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results
MT
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
AQ
Ventyx Biosciences, Inc. Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
CI
Transcript : Ventyx Biosciences, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 12:00 PM
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
AQ
Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise
MT
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
AQ
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
CI
Transcript : Ventyx Biosciences, Inc., Q1 2024 Earnings Call, May 09, 2024
Ventyx Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress
AQ
Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
AQ
VTYX DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
PR
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)
BU
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VTYX Stock
  4. News Ventyx Biosciences, Inc.